Utama › Kardiomiopati › Pennsylvania
Kajian klinikal Kardiomiopati di Pennsylvania
6 kajian untuk Kardiomiopati sedang mencari peserta di lokasi di Pennsylvania.
Bandar di Pennsylvania
Teks kajian rasmi (Bahasa Inggeris)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Lancaster
- Clinical Trial Site, Philadelphia
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Philadelphia
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07358078Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Penn Presbyterian Medical Center, Philadelphia
- University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- University of Pennsylvania, Philadelphia
- UPMC, Pittsburgh
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05034432A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
Umur 8 ke atas · Lelaki · Dikemas kini 4 Mei 2026 · NCT06092034MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Penn Presbyterian Medical Center, Philadelphia
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06128629Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.